Related Experiment Video
Updated: Jun 17, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
HIV protease inhibitors block oral epithelial cell DNA synthesis
Robert J Danaher1, Chunmei Wang, Andrew T Roland
1Department of Oral Health Practice, University of Kentucky, Lexington, KY 40536-0297, USA.
Objectives:
Anti-retroviral therapy regimens that include HIV protease inhibitors (PIs) are associated with diverse adverse effects including increased prevalence of oral warts, oral sensorial deficits and gastrointestinal toxicities suggesting that PIs may perturb epithelial cell biology. To test the hypothesis that PIs could affect specific biological processes of oral epithelium, the effects of these agents were evaluated in several oral epithelial cell-lines.
Design:
Primary and immortalized oral keratinocytes and squamous carcinoma cells of oropharyngeal origin were cultured in the presence of pharmacologically relevant concentrations of PIs. Their affects on cell viability, cytotoxicity and DNA synthesis were assessed by enzymatic assays and incorporation of 5-bromo-2'-deoxyuridine (BrdU) into DNA.
Results:
Viability of primary and immortalized oral keratinocytes as well as squamous carcinoma cells of oropharyngeal origin was significantly reduced by select PIs at concentrations found in plasma. Of the seven PIs evaluated, nelfinavir was the most potent with a mean 50% inhibitory concentration [IC(50)] of 4.1 microM. Lopinavir and saquinavir also reduced epithelial cell viability (IC(50) of 10-20 microM). Atazanavir and ritonovir caused minor reductions in viability, while amprenavir and indinavir were not significant inhibitors. The reduced cell viability, as shown by BrdU incorporation assays, was due to inhibition of DNA synthesis rather than cell death due to cytotoxicity.
Conclusion:
Select PIs retard oral epithelial cell proliferation in a drug and dose-dependent manner by blocking DNA synthesis. This could account for some of their adverse effects on oral health.
Insights
Certain HIV protease inhibitors (PIs) reduce oral epithelial cell proliferation by inhibiting DNA synthesis. This finding may explain adverse oral health effects associated with PI therapy.
Area of Science:
- Cell Biology
- Pharmacology
- Oral Health
Background:
- Anti-retroviral therapy (ART) regimens containing HIV protease inhibitors (PIs) are linked to adverse effects like oral warts and gastrointestinal issues.
- These side effects suggest PIs may impact epithelial cell biology, particularly in the oral cavity.
Purpose of the Study:
- To investigate the effects of PIs on the biological processes of oral epithelium.
- To determine if PIs perturb oral epithelial cell function.
Main Methods:
- Oral keratinocytes and squamous carcinoma cells were cultured with pharmacologically relevant concentrations of PIs.
- Cell viability, cytotoxicity, and DNA synthesis were assessed using enzymatic assays and BrdU incorporation.
Main Results:
- Select PIs significantly reduced the viability of oral epithelial cells at plasma-relevant concentrations.
- Nelfinavir was the most potent inhibitor, followed by lopinavir and saquinavir.
- Reduced viability was attributed to the inhibition of DNA synthesis, not cytotoxicity.
Conclusions:
- Certain PIs inhibit oral epithelial cell proliferation in a drug- and dose-dependent manner by blocking DNA synthesis.
- This mechanism may explain some of the adverse oral health effects observed in patients on PI-based ART.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Retrovirus Life Cycles
Inhibitors of Bacterial DNA Synthesis

